Neuroscience isn't currently one of the top strategic R&D priorities at GSK, but a new alliance with ABL Bio adds to the sense that its focus may be shifting. The UK-headquartered pharma group is ...

SAN FRANCISCO — ABL Bio is closing in on another partnership with a global pharmaceutical company for its proprietary Grabody-B technology, a blood-brain barrier shuttle platform designed to improve ...

Java Development Kit (JDK) 26, a planned update to standard Java due March 17, 2026, has reached the initial release candidate (RC) stage. The RC is open for critical bug fixes, with the feature set ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

"2026 will be a year when ABL Bio's technology licensing and clinical trial results are both crucial." On the 14th (local time) in San Francisco, at the JP Morgan Healthcare Conference, Chief ...

The chimeric BCR–ABL oncoprotein is the molecular hallmark of chronic myelogenous leukemia (CML). BCR–ABL contains nuclear import and export signals but it is localized only in the cytoplasm where it ...

Compact and reliable, the ABL80 FLEX analyzer – BASIC version is a cost-effective choice for blood gas, electrolyte and lactate analysis. Its standby mode reduces the costs for consumables while the ...

The ABL90 FLEX PLUS delivers lab-quality results at the point of care for more confident treatment decisions. Continuous automatic quality management (AQM) provides automatic quality control, ...